Abstract
Death from anthrax has been reported to occur from systemic shock. The lethal toxin (LeTx) is the major effector of anthrax mortality. Although the mechanism of entry of this toxin into cells is well understood, its actions once inside the cell are not as well understood. LeTx is known to cleave and inactivate mitogen activated protein kinase kinases (MAPKKs). We have recently shown that LeTx represses the glucocorticoid receptor both in vitro and in vivo. This repression is partial and specific, showing some receptor specificity and some promoter specificity.This toxin does not affect glucocorticoid receptor (GR) ligand binding or DNA binding in an in vitro electrophoretic mobility shift assay using a DNA probe. However, in chromatin immunoprecipitation assays, LeTx prevents GR binding to chromatin. We have suggested that LeTx may function by removing/inactivating one or more of the many cofactors and/or accessory proteins involved in nuclear hormone receptor signaling. Although the precise involvement of this nuclear hormone receptor repression in LeTx toxicity is unknown, examples of blunted hypothalamic-pituitary-adrenal (HPA) axis and glucocorticoid signaling in numerous autoimmune/inflammatory diseases suggest that such repression of critically important receptors could have deleterious effects on health. In addition, removal of endogenous glucocorticoids and treatment with glucocorticoids (in LT-resistant mice) increases susceptibility to LeTx, suggesting that a precise balance of glucocorticoid levels is required for LeTx survival.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrami, L., Liu, S., Cosson, P., Leppla, S.H., and van der Goot, F.G. (2003). Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell. Biol. 160:321–328.
Abrami, L., Lindsay, M., Parton, R.G., Leppla, S.H., and van der Goot, F.G. (2004). Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J. Cell. Biol. 166:645–651.
Adcock, I.M. (2000). Molecular mechanisms of glucocorticosteroid actions. Pulm. Pharmacol. Ther. 13:115–126.
Agrawal, A., Lingappa, J., Leppla, S.H., Agrawal, S., Jabbar, A., Quinn, C., and Pulendran, B. (2003). Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424:329–334.
Aranda, A., and Pascual, A. (2001). Nuclear hormone receptors and gene expression. Physiol. Rev. 81:1269–1304.
Bergman, N.H., Passalacqua, K.D., Gaspard, R., Shetron-Rama, L.M., Quackenbush, J, and Hanna, P.C. (2005). Murine macrophage transcriptional responses to Bacillus anthracis infection and intoxication. Infect. Immun. 73:1069–1080.
Blaustein, R.O., Koehler, T.M., Collier, R.J., and Finkelstein, A. (1989). Anthrax toxin: Channel-forming activity of protective antigen in planar phospholipid bilayers. Proc. Natl. Acad. Sci. U.S.A. 86:2209–2213.
Bodwell, J.E., Kingsley, L.A., and Hamilton, J.W. (2004). Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: Complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem. Res. Toxicol. 17:1064–1076.
Bradley, K.A., Mogridge, J., Mourez, M., Collier, R.J., and Young, J.A. (2001). Identification of the cellular receptor for anthrax toxin. Nature 414:225–229.
Bray, P.J., and Cotton, R.G. (2003). Variations of the human glucocorticoid receptor gene (NR3C1): Pathological and in vitro mutations and polymorphisms. Hum. Mutat. 21:557–568.
Brogan, I.J., Murray, I.A., Cerillo, G., Needham, M., White, A., and Davis, J.R.E. (1999). Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-eB: Lack of effect of glucocorticoid receptor Β. Mol. Cell. Endocrinol. 157:95–104.
Buske-Kirschbaum, A., and Hellhammer, D.H. (2003). Endocrine and immune responses to stress in chronic inflammatory skin disorders. Ann. N.Y. Acad. Sci. 992:231–240.
Buske-Kirschbaum, A., Jobst, S., Psych, D., Wustman, A., Kirschbaum, C., Rauh, W., and Hellhammer, D. (1997). Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom. Med. 59:419–426.
Buske-Kirschbaum, A., Jobst, S., and Hellhammer, D.H. (1998). Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: Pathologic factor or symptom? Ann. N. Y. Acad. Sci. 840:747–754.
Buske-Kirschbaum, A., VonAuer, K., Krieger, S., Weis, S., Rauh, W., and Hellhammer, D. (2003). Blunted cortisol responses to psychosocial stress in asthmatic children: A general feature of atopic disease? Psychosom. Med. 65: 806–810.
Calis, M., Gokce, C., Ates, F., Ulker, S., Izgi, H.B., Demir, H., Kirnap, M., Sofuoglu, S., Durak, A.C., Tutus, A., and Kelestimur, E (2004). Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J. Endocrinol. Invest. 27: 42–46.
Carlstedt-Duke, J. (1999). Glucocorticoid receptor Β: View II. Trends Endocrinol. Metab. 10:339–342.
Cash, J.M., Crofford, L.J., Gallucci, W.T., Sternberg, E.M., Gold, P.W., Chrousos, G.P., and Wilder, R.L. (1992). Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. J. Rheumatol. 19:1692–1696.
Castagliuolo, I., Karalis, K., Valenick, L., Pasha, A., Nikulasson, S., Wlk, M., and Pothoulakis, C. (2001). Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats. Am. J. Physiol. 280:G539–545.
Chandra, H., Gupta, P.K., Sharma, K., Mattoo, A.R., Garg, S.K., Gade, W.N., Sirdeshmukh, R., Maithal, K., and Singh, Y. (2005). Proteome analysis of mouse macrophages treated with anthrax lethal toxin. Biochim. Biophys. Acta 1747: 151–159.
Chikanza, I.C. (2002). Mechanisms of corticosteroid resistance in rheumatoid arthritis: A putative role for the corticosteroid receptor beta isoform. Ann. N.Y. Acad. Sci. 966:39–48.
Chikanza, I.C., Petrou, P., Kingsley, G., Chrousos, G.P., and Panayi, G.S. (1992): Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35:1281–1288.
Cole, T.J., Blendy, J.A., Monaghan, A.P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., and Schutz, G (1995). Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9:1608–1621.
Collier, R.J., and Young, J.A. (2003). Anthrax toxin. Annu. Rev. Cell. Dev. Biol. 19: 45–70.
Comer, J.E., Galindo, C.L., Chopra, A.K., and Peterson, J.W. (2005). Genechip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis. Infect. Immun. 73:1879–1885.
Crofford, L.J. (2002). The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases. Endocrinol. Metab. Clin. North Am. 31:1–13.
Crofford, L.J., Pillemer, S.R., Kalogeras, K.T., Cash, J.M., Michelson, D., Kling, M.A., Sternberg, E.M., Gold, P.W., Chrousos, G.P., and Wilder, R.L. (1994): Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthitis Rheum. 37:1583–1592.
Crofford, L.J., Kalogeras, K.T., Mastorakos, G., Magiakou, M.A., Wells, J., Kanik, K.S., Gold, P.W., Chrousos, G.P., and Wilder, R.L. (1997): Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82:1279–1283.
Crofford, L.J., Young, E.A., Engleberg, N.C., Korszun, A., Brucksch, C.B., McClure, L.A., Brown, M.B., and Demitrack, M.A. (2004). Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav. Immun. 18:314–325.
Cui, X., Moayeri, M., Li, Y., Li, X., Haley, M., Fitz, Y., Correa-Araujo, R., Banks, S.M., Leppla, S.H., and Eichacker, P.Q. (2004). Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am. J. Physiol. 286:R699–709.
Cutolo, M., Foppiani, L., Perete, C., Ballarino, P., Sulli, A., Villaggio, B., Seriolo, B., Giusti, M., and Accardo, S. (1999): Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J. Rheumatol. 26:282–288.
De Bosscher, K., Vanden Berghe, W., and Haegeman, G. (2003). The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression. Endocr. Rev. 24:488–522.
Demitrack, M.A., and Crofford, L.J. (1998). Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 840:684–697.
Demitrack, M.A., Dale, J.K., Straus, S.E., Laue, L., Listwak, S.J., Kruesi, M.J., Chrousos, G.P., and Gold, P.W. (1991): Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 73:1224–1234.
DeRijk, R.H., Schaaf, M.J., Turner, G., Datson, N.A., Vreugdenhil, E., Cidlowski, J., de Kloet, E.R., Emery, P., Sternberg, E.M., and Detera-Wadleigh, S.D. (2001). A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 28:2383–2388.
Diaz-Borjon, A., Richaud-Patin, Y., Alvarado de la Barrera, C., Jakez-Ocampo, J., Ruiz-Arguelles, A., and Llorente, L. (2000). Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control. Joint Bone Spine 67:40–48.
Dorner, C., Ciossek, T., Muller, S., Moller, P.H., Ullrich, A., and Lammers, R. (1998): Characterization of Kif1c, a new kinesin-like protein involved in vesicle transport from the golgi apparatus to the endoplasmic reticulum. J. Biol. Chem. 273: 20267–20275.
Drouin, J., Sun, Y.L., and Nemer, M. (1989). Glucocorticoid repression of pro-opiomelanocortin gene transcription. J. Steroid Biochem. 34:63–69.
Duesbery, N.S., Webb, C.P., Leppla, S.H., Gordon, V.M., Klimpel, K.R., Copeland, T.D., Ahn, N.G., Oskarsson, M.K., Fukasawa, K., Paull, K.D., and VandeWoude, G.F. (1998). Proteolytic inactivation of map-kinase-kinase by anthrax lethal factor. Science 280:734–737.
Edwards, C.K.I., Yunger, L.M., Lorence, R.M., Dantzer, R., and Kelley, K.W. (1991). The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc. Natl. Acad. Sci. U.S.A. 88:2274–2277.
Eijsbouts, A.M., and Murphy, E.P. (1999). The role of the hypothalamic-pituitary-adrenal axis in rheumatoid arthritis. Baillieres Best Pract. Res. Clin. Rheumatol. 13:599–613.
Erwin, J.L., DaSilva, L.M., Bavari, S., Little, S.F., Friedlander, A.M., and Chanh, T.C. (2001). Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect. Immun. 69:1175–1177.
Evans, R.M. (1988). The steroid and thyroid hormone receptor superfamily. Science 240:889–895.
Ezzell, J.W., Ivins, B.E., and Leppla, S.H. (1984). Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect. Immun. 45:761–767.
Fakhri, S., Christodoulopoulos, P., Tulic, M., Fukakusa, M., Frenkiel, S., Leung, D.Y., and Hamid, Q. A. (2003). Role of microbial toxins in the induction of glucocorticoid receptor beta expression in an explant model of rhinosinusitis. J. Otolaryngol. 32:388–393.
Fakhri, S., Tulic, M., Christodoulopoulos, P., Fukakusa, M., Frenkiel, S., Leung, D.Y., and Hamid, Q.A. (2004). Microbial superantigens induce glucocorticoid receptor beta and steroid resistance in a nasal explant model. Laryngoscope 114:887–892.
Farrell, R.J., Murphy, A., Long, A., Donnelly, S., Cherikuri, A., O’Toole, D., Mahmud, N., Keeling, P.W., Weir, D.G., and Kelleher, D. (2000). High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118:279–288.
Fish, D.C., Klein, F., Lincoln, R.E., Walker, J.S., and Dobbs, J.P. (1968). Pathophysiological changes in the rat associated with anthrax toxin. J. Infect. Dis. 118: 114–124.
Friedlander, A.M. (1986). Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261:7123–7126.
Friedlander, A.M., Bhatnagar, R., Leppla, S.H., Johnson, L., and Singh, Y. (1993). Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 61:245–252.
Gaab, J., Huster, D., Peisen, R., Engert, V., Heitz, V., Schad, T., Schurmeyer, T.H., and Ehlert, U. (2002). Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom. Med. 64:951–962.
Gaab, J., Engert, V., Heitz, V., Schad, T., Schurmeyer, T.H., and Ehlert, U. (2004). Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J. Psychosom. Res. 56:419–424.
Gutierrez, M.A., Garcia, M.E., Rodriguez, J.A., Rivero, S., and Jacobelli, S. (1998). Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus 7:404–408.
Gutierrez, M.A., Garcia, M.E., Rodriguez, J.A., Mardonez, G., Jacobelli, S., and Rivero, S. (1999). Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: A controlled study using insulin hypoglycemia stress test and prolactin stimulation. J. Rheumatol. 26:277–281.
Gómez, F., deKloet, E.R., and Armario, A. (1998). Glucocorticoid negative feedback on the HPA axis in five inbred rat strains. Am. J. Physiol. 274:R420–R427.
Haarman, E.G., Kaspers, G.J., Pieters, R., Rottier, M.M., and Veerman, A.J. (2004). Glucocorticoid receptor alpha, beta and gamma expression vs. in vitro glucocorticoid resistance in childhood leukemia. Leukemia 18:530–537.
Hamid, Q.A., Wenzel, S.E., Hauk, P.J., Tsicopoulos, A., Wallaert, B., Lafitte, J.-J., Chrousos, G.P., Szefler, S.J., and Leung, D.Y.M. (1999). Increased glucocorticoid receptor Β in airway cells of glucocorticoid-insensitive asthma. Am. J. Respir. Crit. Care Med. 159:1600–1604.
Hamilos, D.L., Leung, D.Y., Muro, S., Kahn, A.M., Hamilos, S.S., Thawley, S.E., and Hamid, Q.A. (2001). GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J. Allergy Clin. Immunol. 108:59–68.
Hammond, S.E., and Hanna, P.C. (1998). Lethal factor active-site mutations affect catalytic activity in vitro. Infect. Immun. 66:2374–2378.
Hamrahian, A.H., Oseni, T.S., and Arafah, B.M. (2004). Measurements of serum free cortisol in critically ill patients. N. Engl. J. Med. 350:1629–1638.
Hanna, P.C., Acosta, D., and Collier, R.J. (1993). On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. U.S.A. 90:10198–10201.
Hecht, K., Carlstedt-Duke, J., Stierna, P., Gustafsson, J.-å., Brönnegård, M., and Wikström, A.-C (1997). Evidence that the Β-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J. Biol. Chem. 272: 26659–26664.
Herrlich, E(2001). Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20:2465–2475.
Hirano, T., Onda, K., Toma, T., Miyaoka, M., Moriyasu, F., and Oka, K. (2004). MDR1 mRNA expressions in peripheral blood mononuclear cells of patients with ulcerative colitis in relation to glucocorticoid administration. J. Clin. Pharmacol. 44: 481–486.
Honda, M., Orii, F., Ayabe, T., Imai, S., Ashida, T., Obara, T., and Kohgo, Y. (2000). Expression of glucocorticoid receptor Β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118:859–866.
Hori, T., Watanabe, K., Miyaoka, M., Moriyasu, F., Onda, K., Hirano, T., and Oka, K. (2002). Expression of mRNA for glucocorticoid receptors in peripheral blood mononuclear cells of patients with Crohn’s disease. J. Gastroenterol. Hepatol. 17: 1070–1077.
Hu, Y., Dietrich, H., Herold, M., Heinrich, P.C., and Wick, G. (1993). Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int. Arch. Allergy Immunol. 102:232–241.
Huitinga, I., Erkut, Z.A., vanBeurden, D., and Swaab, D.F. (2003). The hypothalamo-pituitary-adrenal axis in multiple sclerosis. Ann. N. Y.Acad. Sci. 992:118–128.
Huizenga, N.A.T.M., Koper, J.W., DeLange, P., Pols, H.A.P., Stolk, R.P., Burger, H., Grobbee, D.E., Brinkmann, A.O., De Jong, F.H., and Lamberts, S.W.J. (1998). A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J. Clin. Endocrinol. Metab. 83: 144–151.
Irusen, E., Matthews, J.G., Takahashi, A., Barnes, P.J., Chung, K.F., and Adcock, I.M. (2002). p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109:649–657.
Jantzen, H.M., Strahle, U., Gloss, B., Stewart, F., Schmid, W., Boshart, M., Miksicek, R., and Schutz, G. (1987). Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49:29–38.
Johnson, E.O., Vlachoyiannopoulos, P.G., Skopouli, F.N., Tzioufas, A.G., and Moutsopoulos, H.M. (1998). Hypofunction of the stress axis in Sjogren’s syndrome. J. Rheumatol. 25:1508–1514.
Kalns, J., Scruggs, J., Millenbaugh, N., Vivekananda, J., Shealy, D., Eggers, J., and Kiel, J. (2002). TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection. Biochem. Biophys. Res. Commun. 292:41–44.
Karin, M., and Chang, L. (2001). AP-1-glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol. 169:447–451.
Kassam, A., Der, S.D., and Mogridge, J. (2005). Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cell. Microbiol. 7:281–292.
Kim, S.O., Jing, Q., Hoebe, K., Beutler, B., Duesbery, N.S., and Han, J. (2003). Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha. J. Biol. Chem. 278:7413–7421.
Kino, T., and Chrousos, G.P. (2001). Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J. Endocrinol. 169:437–445.
Kino, T., Gragerov, A., Kopp. J.B., Stauber, R.H., Pavlakis, G.N., and Chrousos, G.P. (1999). The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor. J. Exp. Med. 189:51–61.
Kirby, J.E. (2004). Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72:430–439.
Klein, F., Hodges, D.R., Mahlandt, B.G., Jones, W.I., Haines, B.W., and Lincoln, R.E. (1962). Anthrax toxin: Causative agent in the death of rhesus monkeys. Science 138:1331–1333.
Klimpel, K.R., Molloy, S.S., Thomas, G., and Leppla, S.H. (1992). Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. U.S.A. 89:10277–10281.
Klimpel, K.R., Arora, N., and Leppla, S.H. (1994). Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093–1100.
Knutti, D., Kressler, D., and Kralli, A. (2001). Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc. Natl. Acad. Sci. U.S.A. 98:9713–9718.
Koper, J.W., Stolk, R.P., De Lange, P., Huizenga, N.A.T.M., Molijn, G.-J., Pols, H.A.P., Grobbee, D.E., Karl, M., De Jong, F.H., Brinkmann, A.O., and Lamberts, S.W.J. (1997). Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum. Genet. 99:663–668.
Kozawa, O., Niwa, M., Hatakeyama, D., Tokuda, H., Oiso, Y., Matsuno, H., Kato, K., and Uematsu, T. (2002). Specific induction of heat shock protein 27 by glucocorticoid in osteoblasts. J. Cell. Biochem. 86:357–364.
Kralli, A.R., and Yamamoto. K.R. (1996). An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271: 17152–17156.
Krstic, M.D., Rogatsky, I., Yamamoto, K.R., and Garabedian, M.J. (1997). Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17:3947–3954.
Lechner, O., Hu, Y., Jafarian Tehrani, M., Dietrich, H., Schwartz, S., Herold, M., Haour, F., and Wick, G. (1996). Disturbed immunoendocine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav. Immun. 10: 337–350.
Leung, D.Y.M., Hamid, Q., Vottero, A., Szefler, S.J., Surs, W., Minshall, E., Chrousos, G.P., and Klemm, D.J. (1997). Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor Β. J. Exp. Med. 186:1567–1574.
Lindsay, R.S., Wake, D.J., Nair, S., Bunt, J., Livingstone, D.E., Permana, P.A., Tataranni, P.A., and Walker, B.R. (2003). Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 88:2738–2744.
Llorente, L., Richaud-Patin, Y., Diaz-Borjon, A., Alvaradode la Barrera, C, Jakez-Ocampo, J., de la Fuente, H., Gonzalez-Amaro, R., and Diaz-Jouanen, E. (2000). Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. Joint Bone Spine 67:30–39.
Lopez, G.N., Turck, C.W., Schaufele, F., Stallcup, M.R., and Kushner, P.J. (2001). Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J. Biol. Chem. 276:22177–22182.
Lucibello, F.C., Slater, E.P., Jooss, K.U., Beato, M., and Muller, R. (1990). Mutual transrepression of Fos and the glucocorticoid receptor: Involvement of a functional domain in Fos which is absent in FosB. EM BO J. 9:2827–2834.
MacPhee, I.A.M., Antoni, F.A., and Mason, D.W. (1989). Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169: 431–445.
McAllister, R.D., Singh, Y., Du Bois, W.D., Potter, M., Boehm, T., Meeker, N.D., Fillmore, P.D., Anderson, L.M., Poynter, M.E., and Teuscher, C. (2003). Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci. Am. J. Pathol. 163:1735–1741.
McCallum, R.E., and Stith, R.D. (1982). Endotoxin-induced inhibition of steroid binding by mouse liver cytosol. Circ. Shock 9:357–367.
McKay, L.I., and Cidlowski, J.A. (1999). Molecular control of immune/inflammatory responses: Interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20:435–459.
Medh, R.D., Lay, R.H., and Schmidt, T.J. (1998). Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants. Mol. Cell. Endocrinol. 138:11–23.
Menard, A., Papini, E., Mock, M., and Montecucco, C. (1996). The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors. Biochem. J. 320:687–691.
Michelson, D., Stone, L., Galliven, E., Magiakou, M.A., Chrousos, G.P., Sternberg, E.M., and Gold, P.W. (1994). Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J. Clin. Endocrinol. Metab. 79:848–853.
Mingrone, G., DeGaetano, A., Pugeat, M., Capristo, E., Greco, A.V., and Gasbarrini, G (1999). The steroid resistance of Crohn’s disease. J. Invest. Med. 47:319–325.
Moayeri, M., Haines, D., Young, H.A., and Leppla, S.H. (2003): Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112:670–682.
Moayeri, M., Martinez, N.W., Wiggins, J., Young, H.A., and Leppla, S.H. (2004). Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect. Immun. 72:4439–4447.
Moayeri, M., Webster, J.I., Wiggins, J.F., Leppla, S.H., and Sternberg, E.M. (2005). Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin. Infect. Immun. 73:4238–4244.
Mock, M., and Fouet, A. (2001). Anthrax. Annu. Rev. Microbiol. 55:647–671.
Moncek, F., Kvetnansky, R., and Jezova, D. (2001). Differential responses to stress stimuli of Lewis and Fischer rats at the pituitary and adrenocortical level. Endocr. Reg. 35:35–41.
Mykoniatis, A., Anton, P.M., Wlk, M., Wang, C.C., Ungsunan, L., Bluher, S., Venihaki, M., Simeonidis, S., Zacks, J., Zhao, D., Sougioultzis, S., Karalis, K., Mantzoros, C., and Pothoulakis, C. (2003). Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 124:683–691.
Neeck, G., and Crofford, L.J. (2000). Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum. Dis. Clin. North Am. 26:989–1002.
New, M.I., Nimkarn, S., Brandon, D.D., Cunningham-Rundles, S., Wilson, R.C., Newfield, R.S., Vandermeulen, J., Barron, N., Russo, C., Loriaux, D.L., and O’Malley, B. (1999). Resistance to several steroids in two sisters. J. Clin. Endocrinol. Metab. 84:4454–4464.
New, M.I., Nimkarn, S., Brandon, D.D., Cunningham-Rundles, S., Wilson, R.C., Newfield, R.S., Vandermeulen, J., Barron, N., Russo, C., Loriaux, D.L., and O’Malley, B. (2001). Resistance to multiple steroids in two sisters. J. Steroid Biochem. Mol. Biol. 76:161–166.
Oakley, R.H., Sar, M., and Cidlowski, J.A. (1996). The human glucocorticoid receptor b isoform. Expression, biochemical properties and putative function. J. Biol. Chem. 271:9550–9559.
Oakley, R.H., Jewell, C.M., Yudt, M.R., Bofetiado, D.M., and Cidlowski, J.A. (1999). The dominant negative activity of the human glucocorticoid receptor Β isoform. Specificity and mechanisms of action. J. Biol. Chem. 274:27857–27866.
Orii, F., Ashida, T., Nomura, M., Maemoto, A., Fujiki, T., Ayabe, T., Imai, S., Saitoh, Y., and Kohgo, Y. (2002). Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD. Biochem. Biophys. Res. Commun. 296:1286–1294.
Paccani, S.R., Tonello, F., Ghittoni, R., Natale, M., Muraro, L., D’Elios, M.M., Tang, W.J., Montecucco, C., and Baldari, C.T (2005). Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 201: 325–331.
Palermo, M., Alves-Rosa, F., Rubel, C., Fernandez, G.C., Fernandez-Alonso, G., Alberto, F., Rivas, M., and Isturiz, M. (2000). Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin. Exp. Immunol. 119:77–83.
Pandey, J., and Warburton, D. (2004). Knock-on effect of anthrax lethal toxin on macrophages potentiates cytotoxicity to endothelial cells. Microbes Infect. 6: 835–843.
Park, J.M., Greten, F.R., Li, Z.W., and Karin, M. (2002). Macrophage apoptosis by anthrax lethal factor through p38 map kinase inhibition. Science 297:2048–2051.
Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. (1999). Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ-induced release of NO and TNFα. FEBS Lett. 462:199–204.
Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. (2000). Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: Analysis of the intracellular consequences in macrophages. Int. J. Med. Microbiol. 290: 421–427.
Pezard, C., Berche, P., and Mock, M. (1991). Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472–3477.
Pickering, A.K., and Merkel, T.J. (2004). Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores. Infect. Immun. 72:3069–3072.
Pickering, A.K., Osorio, M., Lee, G.M., Grippe, V.K., Bray, M., and Merkel, T.J. (2004). Cytokine response to infection with Bacillus anthracis spores. Infect. Immun. 72:6382–6389.
Popov, S.G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Popova, T., Wu, A., Alibek, D., Bailey, C., and Alibek, K. (2002a). Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527:211–215.
Popov, S.G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Wu, A., Alibek, D., Bailey, C., and Alibek, K. (2002b). Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293:349–355.
Popov, S.G., Popova, T.G., Grene, E., Klotz, F., Cardwell, J., Bradburne, C., Jama, Y., Maland, M., Wells, J., Nalca, A., Voss, T., Bailey, C., and Alibek, K. (2004). Systemic cytokine response in murine anthrax. Cell. Microbiol. 6:225–233.
Pujols, L., Mullol, J., Benitez, P., Torrego, A., Xaubet, A., de Haro, J., and Picado, C. (2003). Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. Respir. Med. 97:90–96.
Pujols, L., Xaubet, A., Ramirez, J., Mullol, J., Roca-Ferrer, J., Torrego, A., Cidlowski, J.A., and Picado, C. (2004). Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases. Thorax 59: 687–693.
Racciatti, D., Guagnano, M.T., Vecchiet, J., De Remigis, P.L., Pizzigallo, E., Della Vecchia, R., Di Sciascio, T., Merlitti, D., and Sensi, S. (2001). Chronic fatigue syndrome: Circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. Int. J. Immunopathol. Pharmacol. 14:11–15.
Rask, E., Olsson, T., Soderberg, S., Andrew, R., Livingstone, D.E., Johnson, O., and Walker, B.R. (2001). Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 86:1418–1421.
Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schütz, G. (1998). DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531–541.
Richaud-Patin, Y., Vega-Boada, F., Vidaller, A., and Llorente, L. (2004). Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients. Biomed. Pharmacother. 58:320–324.
Roberts, J.E., Watters, J.W., Ballard, J.D., and Dietrich, W.F. (1998). Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11. Mol. Microbiol. 29:581–591.
Roberts, A.D., Wessely, S., Chalder, T., Papadopoulos, A., and Cleare, A.J. (2004). Salivary cortisol response to awakening in chronic fatigue syndrome. Br. J. Psychiatry 184:136–141.
Rogatsky, I., Logan, S.K., and Garabedian, M.J. (1998). Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 95:2050–2055.
Rupprecht, M., Hornstein, O.P., Schluter, D., Schafers, H.J., Koch, H.U., Beck, G., and Rupprecht, R. (1995). Cortisol, corticotropin, and beta-endorphin responses to corticotropin-releasing hormone in patients with atopic eczema. Psychoneuroendocrinology 20:543–551.
Ruzek, M.C., Pearce, B.D., Miller, A.H., and Biron, C.A. (1999). Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J. Immunol. 162:3527–3533.
Schlaghecke, R., Kornely, E., Wollenhaupt, J., and Specker, C. (1992). Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 35:740–744.
Schoneveld, O.J., Gaemers, I.C., and Lamers, W.H. (2004). Mechanisms of glucocorticoid signalling. Biochim. Biophys. Acta 1680:114–128.
Schule, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M., and Evans, R.M. (1990). Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217–1226.
Scobie, H.M., Rainey, G.J., Bradley, K.A., and Young, J.A. (2003). Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. U.S.A. 100:5170–5174.
Seckl, J.R., and Walker, B.R. (2001). Minireview: 11Β-hydroxysteroid dehydrogenase type 1—A tissue-specific amplifier of glucocorticoid action. Endocrinology 142: 1371–1376.
Seckl, J.R., Morton, N.M., Chapman, K.E., and Walker, B.R. (2004). Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog. Horm. Res. 59:359–393.
Shahidi, H., Vottero, A., Stratakis, C., Taymans, S.E., Karl, M., Longui, C.A., Chrousos, G.P., Daughaday, W.H., Gregory, S.A., and Plate, J.M.D. (1999). Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem. Biophys. Res. Commun. 254:559–565.
Shanks, N., Griffiths, J., Zalcman, S., Zacharko, R.M., and Anisman, H. (1990). Mouse strain differences in plasma corticosterone following uncontrollable footshock. Pharmacol. Biochem. Behav. 36:515–519.
Shin, S., Hur, G.H., Kim, Y.B., Yeon, G.B., Park, K.J., Park, Y.M., and Lee, W.S. (2000). Dehydroepiandrosterone and melatonin prevent Bacillus anthracis lethal toxininduced TNF production in macrophages. Cell. Biol. Toxicol. 16:165–174.
Singh, Y., Leppla, S.H., Bhatnagar, R., and Friedlander, A.M. (1989). Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and-resistant cells. J. Biol. Chem. 264:11099–11102.
Singh, Y., Klimpel, K.R., Goel, S., Swain, P.K., and Leppla, S.H. (1999). Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect. Immun. 67:1853–1859.
Smith, H., Keppie. J., Stanley, J.L., and Harris-Smith, P.W (1955). The chemical basis of the virulence of Bacillus anthracis. IV: Secondary shock as the major factor in death of guinea-pigs from anthrax. Br. J. Exp. Pathol. 36:323–335.
Smoak, K.A., and Cidlowski, J. A. (2004). Mechanisms of glucocorticoid receptor signaling during inflammation. Mech. Ageing Dev. 125:697–706.
Sousa, A.R., Lane, S.J., Cidlowski, J.A., Staynov, D.Z., and Lee, T.H. (2000). Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J. Allergy Clin. Immunol. 105:943–950.
Sternberg, E.M., Hill, J.M., Chrousos, G.P., Kamilaris, T., Listwak, S.J., Gold, P.W., and Wilder, R.L. (1989a). Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. U.S.A. 86:2374–2378.
Sternberg, E.M., Young, W.S.d., Bernardini, R., Calogero, A.E., Chrousos, G.P., Gold, P.W., and Wilder, R.L. (1989b). A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. U.S.A. 86:4771–4775.
Strickland, I., Kisich, K., Hauk, P.J., Vottero, A., Chrousos, G.P., Klemm, D.J., and Leung, D.Y.M. (2001). High constitutive glucocorticoid receptor Β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J. Exp. Med. 193:585–593.
Szatmary, Z., Garabedian, M.J., and Vilcek, J. (2004). Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J. Biol. Chem. 279:43708–43715.
Takahasi, K.I., Fukushima, K., Sasano, H., Sasaki, I., Matsuno, S., Krozowski, Z.S., and Nagura, H. (1999). Type II 11beta-hydroxysteroid dehydrogenase expression in human colonic epithelial cells of inflammatory bowel disease. Dig. Dis. Sci. 44: 2516–2522.
Thompson, B.T. (2003). Glucocorticoids and acute lung injury. Crit. Care Med. 31: S253–257.
Valledor, A.F., Hsu, L.C., Ogawa, S., Sawka-Verhelle, D., Karin, M., and Glass, C.K. (2004). Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl.Acad. Sci. U.S.A. 101:17813–17818.
Valsamakis, G., Anwar, A., Tomlinson, J.W., Shackleton, C.H., McTernan, P.G., Chetty, R., Wood, P.J., Banerjee, A.K., Holder, G., Barnett, A.H., Stewart, P.M., and Kumar, S. (2004). 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89:4755–4761.
Valtysdottir, S.T., Wide, L., and Hallgren, R. (2001). Low serum dehydroepiandrosterone sulfate in women with primary Sjogren’s syndrome as an isolated sign of impaired HPA axis function. J. Rheumatol. 28:1259–1265.
Vermes, I., and Beishuizen, A. (2001). The hypothalamic-pituitary-adrenal response to critical illness. Best Pract. Res. Clin. Endocrinol. Metab. 15:495–511.
Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco, C. (1998). Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706–711.
Vottero, A., and Chrousos, G.P. (1999). Glucocorticoid receptor Β: View I. Trends Endocrinol. Metab. 10:333–338.
Wang, X., Wu, H., and Miller, A.H. (2004). Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Mol. Psychiatry 9:65–75.
Watters, J.W., Dewar, K., Lehoczky, J., Boyartchuk, V., and Dietrich, W.F. (2001). Kif1c, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor. Curr. Biol. 11:1503–1511.
Webster, J.I., and Carlstedt-Duke, J. (2002). Involvement of multidrug-resistance proteins (MDR) in the modulation of glucocorticoid response. J. Steroid Biochem. Mol. Biol. 82:277–288.
Webster, J.I., and Sternberg, E.M. (2004). Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J. Endocrinol. 181:207–221.
Webster, J.I., and Sternberg, E.M. (2005). Anthrax lethal toxin represses glucocorticoid receptor (GR) transactivation by inhibiting GR-DNA binding in vivo. Mol. Cell. Endocrinol. 241:21–31.
Webster, J.I., Tonelli, L., and Sternberg, E.M. (2002). Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20:125–163.
Webster, J.I., Tonelli, L.H., Moayeri, M., Simons, S.S., Jr., Leppla, S.H., and Sternberg, E.M. (2003). Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc. Natl. Acad. Sci. U.S.A. 100:5706–5711.
Wei, T., and Lightman, S.L. (1997). The neuroendocrine axis in patients with multiple sclerosis. Brain 120:1067–1076.
Wesche, J., Elliott, J.L., Falnes, P.O., Olsnes, S., and Collier, R.J. (1998). Characterization of membrane translocation by anthrax protective antigen. Biochemistry 37: 15737–15746.
Westerbacka, J., Yki-Jarvinen, H., Vehkavaara, S., Hakkinen, A.M., Andrew, R., Wake, D.J., Seckl, J.R., and Walker, B.R. (2003). Body fat distribution and cortisol metabolism in healthy men: Enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J. Clin. Endocrinol. Metab. 88:4924–4931.
Wick, G., Sgonc, R., and Lechner, O. (1998). Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann. N. Y. Acad. Sci. 840:591–598.
Wilder, R.L., Calandra, G.B., Garvin, A.J., Wright, K.D., and Hansen, C.T. (1982). Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum. 25:1064–1072.
Zhao, J., Milne, J.C., and Collier, R.J. (1995). Effect of anthrax toxin’s lethal factor on ion channels formed by the protective antigen. J. Biol. Chem. 270:18626–18630.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Webster, J.I., Moayeri, M., Sternberg, E.M. (2006). Anthrax Lethal Factor Represses Glucocorticoid and Progesterone Receptor Activity. In: Welsh, C.J., Meagher, M.W., Sternberg, E.M. (eds) Neural and Neuroendocrine Mechanisms in Host Defense and Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-48334-4_4
Download citation
DOI: https://doi.org/10.1007/978-0-387-48334-4_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-31411-2
Online ISBN: 978-0-387-48334-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)